pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
0
catalysts
Phase 2
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
0
catalysts
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIB
BIOGEN INC.
0
catalysts
← prev
page 237 of 271
next →
131
Pain
89
Neurology
1
Phase 2
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
0
catalysts
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
0
catalysts
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
0
catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTL
Autolus Therapeutics plc
0
catalysts
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0
catalysts
Phase 1
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
0
catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19
Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIO
Zenas BioPharma, Inc.
0
catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0
catalysts
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
0
catalysts
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
0
catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
0
catalysts
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
0
catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0
catalysts
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Somatostatin receptor
Camurus AB
0
catalysts
Preclinical
octreotide acetate
Octreotide Acetate (octreotide acetate)
Intracranial Hypertension
NBO Pharma LLC
0
catalysts
Marketed
octreotide acetate DR
Mycapssa (octreotide acetate)
Acromegaly
Chiasma Inc
0
catalysts
Marketed
octreotide acetate LA
Sandostatin LAR (octreotide acetate)
Diarrhea
$NVS
NOVARTIS AG
0
catalysts
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
OBI Pharma Inc
0
catalysts
Phase 2
odatroltide
odatroltide [INN]
Acute Ischemic Stroke
Lumosa Therapeutics Co Ltd
0
catalysts
Phase 3
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD20
T cell surface glycoprotein CD3
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
0
catalysts
pre_registration
olanzapine ER
olanzapine
Schizophrenia
D2-like dopamine receptor
5-hydroxytryptamine receptor 2C
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Marketed
olanzapine pamoate XR
Zyprexa Relprevv (olanzapine pamoate)
Schizophrenia
CHEPLAPHARM Arzneimittel GmbH
0
catalysts
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
0
catalysts
Phase 2
olastrocel
olastrocel [INN]
Type 1 Diabetes (Juvenile Diabetes)
$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
0
catalysts
Phase 2
olatorepatide
olatorepatide [INN]
Obesity
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts